Our Products
Loans
Cards
Insurance
Investment
Stock Market
Electronics Mall
CIBIL Score
Knowledge Centre
Academy 
Calculators
Our Services
My Account
Do not call
En
Nifty Healthcare Index
Nifty Healthcare Index Performance
Day's Range
Low
₹16,475.45
High
₹16,651.55
52 Week Range
Low
₹13,536.50
High
₹16,941.70
| Previous Close | ₹16,520.30 |
|---|---|
| Day's Range | ₹16,475.45 - ₹16,651.55 |
| Open | ₹16,525.15 |
| 52 Week Range | ₹13,536.50 - ₹16,941.70 |
| Volume | 4,89,72,200 |
Nifty Healthcare Index Companies
| Company Name | LTP (₹) | Change (₹) | Sector |
|---|---|---|---|
| Cipla Ltd. | 1384.00 |  -11.00 (-0.79%) |
Healthcare |
| Dr. Reddy's Laboratories Ltd. | 1151.00 |  6.80 (0.59%) |
Healthcare |
| Lupin Ltd. | 2104.70 | -0.30 (-0.01%) |
Healthcare |
| Torrent Pharmaceuticals Ltd. | 4960.00 | 46.00 (0.94%) |
Healthcare |
| Abbott India Ltd. | 25555.00 | -385.00 (-1.48%) |
Healthcare |
| Apollo Hospitals Enterprise Ltd. | 8837.50 | 77.50 (0.88%) |
Healthcare |
| Ipca Laboratories Ltd. | 1967.20 | 8.10 (0.41%) |
Healthcare |
| Sun Pharmaceutical Industries Ltd. | 1885.90 | -9.10 (-0.48%) |
Healthcare |
| Aurobindo Pharma Ltd. | 1692.00 | 32.00 (1.93%) |
Healthcare |
| Glenmark Pharmaceuticals Ltd. | 2474.50 | 22.60 (0.92%) |
Healthcare |
| Index Name | Market Value | 52W High | 52W Low |
|---|---|---|---|
| Nifty 50 | 23635.1 | 26373.20 | 22182.55 |
| Nifty IT | 29883.5 | 40301.40 | 25699.10 |
| Nifty Next 50 | 72950.65 | 75000.40 | 59896.10 |
| NIFTY50 USD Index | 8636.8 | 10443.40 | 8132.40 |
| Nifty Bank | 56777.55 | 61764.85 | 49954.85 |
| NIFTY Midcap 100 | 62915.8 | 64450.90 | 52032.85 |
| Nifty 500 | 23106.1 | 24144.20 | 20385.65 |
| Nifty Midcap 50 | 18093.0 | 18500.95 | 14804.55 |
| Nifty 100 | 24803.9 | 26975.15 | 22720.45 |
| Nifty FMCG | 45749.85 | 57445.20 | 45334.15 |
Latest News
Biocon informs about press release
Biocon has informed that it enclosed the press release titled ‘Biocon Secures 10-Year Supply Contract for Pertuzumab in Brazil’. The above information will also be available on the website of the Company at www.biocon.com.
The above information is a part of company’s filings submitted to BSE.
Max Healthcare Institute informs about allotment of equity shares
Max Healthcare Institute has informed that Nomination & Remuneration Committee (‘NRC’) of the Company today, September 4, 2026, at 8.52 am (IST), has approved the allotment of 33,765 equity shares having face value of ₹10 each, fully paid-up, to eligible employees, consequent to the exercise of vested stock options in accordance with Max Healthcare Institute - Employee Stock Option Scheme 2022. Consequent to the above allotment, the paid-up equity share capital of the Company stands increased from 973,27,64,860 to 973,31,02,510. In terms of regulation 10(c) of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021, the requisite details of equity shares allotted as above are enclosed as Annexure. This disclosure will also be hosted on Company's website: www.maxhealthcare.in.
The above information is a part of company’s filings submitted to BSE.
Aurobindo Pharma informs about disclosure
Aurobindo Pharma has informed that, Pharma Private, a wholly owned subsidiary of the Company has incorporated a new wholly owned subsidiary by the name of ‘Avogent Lifesciences’ in India. The disclosure pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and Part A of Schedule III of the aforesaid regulations, is attached as ‘Annexure A’.
The above information is a part of company’s filings submitted to BSE.
Sun Pharmaceutical Industries informs about press release
Laurus Labs submits analyst meet intimation
No Records Found
Sign in to Unlock Offers!
We don't SPAM
Frequently Asked Questions
The previous close of NIFTYHEALTH index is ₹16624.6 as of 2026-09-08.
The total volume of NIFTYHEALTH index is 48972200.00 as of 2026-09-08.
The percentage change in value of NIFTYHEALTH index is 0.63% as of 2026-09-08.
The absolute increase in NIFTYHEALTH index value since the previous trading day is ₹104.3 as of 2026-09-08.
A stock reaching its 52-week high indicates it has attained its highest price point in the past year. This milestone may signal strong performance and positive investor sentiment. Please note that investments are subject to market risks.
Disclaimer
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.
